Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam.
In vitro protein binding studies were conducted to examine the interaction between ceftriaxone (CEF), probenecid (PROB) and diazepam (DIAZ). The presence of PROB and DIAZ at concentrations equal to molar albumin concentration caused a decrease in CEF affinity from 3.7 x 10(4) M-1 (control) to 1.1 x 10(4) (PROB) and 2.6 x 10(4) (DIAZ) M-1, but not in binding capacity in pooled human plasma. PROB and DIAZ at five times the molar albumin concentration also caused a decrease in CEF affinity from 4.5 x 10(4) M-1 (control) to 0.45 x 10(4) (PROB) and 3.0 x 10(4) (DIAZ) M-1 in isolated human serum albumin. DIAZ and PROB displaced one another, confirming their common binding site (Site II, the benzodiazepine site) on serum albumin. By contrast, CEF was unable to displace either PROB or DIAZ from defatted albumin. In the presence of elevated free fatty acid concentrations (four times the albumin concentration), CEF decreased the binding of both drugs. CEF free fraction (fp) in isolated human serum albumin (CEF fp = 7.7%) was increased by drugs which bind to Site I: sulfisoxazole (CEF fp = 68.1%), warfarin (CEF fp = 56.0%) and furosemide (CEF fp = 55.0%). At ten times the molar concentration of albumin, CEF displaced both warfarin (warfarin fp from 0.99 to 2.20%) and phenytoin (phenytoin fp from 17.7 to 23.4%) from defatted albumin. CEF appeared to bind to Site I (the warfarin site) on human serum albumin, and was displaced by PROB and DIAZ via a mechanism which did not involve direct competition at a common binding site.
McNamara
P J
PJ
College of Pharmacy, University of Kentucky, Lexington 40536.
Trueb
V
V
Stoeckel
K
K
D001665:Binding Sites; D001798:Blood Proteins / Q000187:drug effects / Q000378:metabolism*; D002443:Ceftriaxone / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D003975:Diazepam / Q000378:metabolism / Q000494:pharmacology*; D004347:Drug Interactions; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006801:Humans; D010672:Phenytoin / Q000378:metabolism; D011339:Probenecid / Q000378:metabolism / Q000494:pharmacology*; D012709:Serum Albumin / Q000378:metabolism*; D014859:Warfarin / Q000378:metabolism
D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D012709:Serum Albumin; D014859:Warfarin; D010672:Phenytoin; D002443:Ceftriaxone; D011339:Probenecid; D003975:Diazepam